Comparison
Abnormal Circulating Glycine Concentration C5139043 vs Abnormal Amplitude Of Pattern Electroretinogram C4072975
Clinical comparison between Abnormal Circulating Glycine Concentration and Abnormal Amplitude OF Pattern Electroretinogram for differential diagnosis and treatment planning.
Abnormal Circulating Glycine Concentration C5139043
A condition where glycine, an amino acid important for nerve function and protein synthesis, is present at abnormal levels in the blood.
Abnormal Amplitude Of Pattern Electroretinogram C4072975
A pattern electroretinogram abnormality suggesting dysfunction of the macula or retinal ganglion cells. Further vision testing is usually needed.
6 comparison axes
Onset
Abnormal Circulating Glycine Concentration C5139043
Variable
Abnormal Amplitude Of Pattern Electroretinogram C4072975
Variable
Onset patterns differ
Severity
Abnormal Circulating Glycine Concentration C5139043
moderate
Abnormal Amplitude Of Pattern Electroretinogram C4072975
moderate
Different severity levels
Chronic
Abnormal Circulating Glycine Concentration C5139043
Chronic
Abnormal Amplitude Of Pattern Electroretinogram C4072975
Chronic
Differing course
Communicable
Abnormal Circulating Glycine Concentration C5139043
No
Abnormal Amplitude Of Pattern Electroretinogram C4072975
No
Different transmission
Body System
Abnormal Circulating Glycine Concentration C5139043
metabolic
Abnormal Amplitude Of Pattern Electroretinogram C4072975
ophthalmologic
Same/different system
Category
Abnormal Circulating Glycine Concentration C5139043
metabolic
Abnormal Amplitude Of Pattern Electroretinogram C4072975
genetic
Different category
Bottom line
abnormal-circulating-glycine-concentration-C5139043 and abnormal-amplitude-of-pattern-electroretinogram-C4072975 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abnormal Circulating Glycine Concentration C5139043 | Abnormal Amplitude Of Pattern Electroretinogram C4072975 | Discriminating power |
|---|---|---|---|
| Primary manifestation | No specific symptom is established; neurologic or metabolic features may occur depending on cause. | May accompany reduced central vision or other visual dysfunction, but symptoms are not definitive. | High |
| Affected system | A circulating amino-acid abnormality involving metabolism. | A retinal electrophysiology abnormality involving the macula or ganglion cells. | High |
| Course clues | May be transient or persistent; chronicity and severity are not fixed by the finding alone. | May persist if retinal dysfunction continues, but progression cannot be assumed. | Moderate |
When to favor each condition
Choose Abnormal Circulating Glycine Concentration C5139043 when
An amino-acid panel shows abnormal glycine
The result directly concerns circulating glycine and needs metabolic interpretation.
High
Unexplained neurologic or metabolic illness
Glycine testing may be relevant, but it does not establish a specific disorder.
Moderate
No visual complaint or retinal concern
An eye electrophysiology label would not explain an isolated blood result.
Moderate
Choose Abnormal Amplitude Of Pattern Electroretinogram C4072975 when
Pattern ERG amplitude is reported as abnormal
The finding specifically concerns macular or retinal ganglion-cell function.
High
Central vision or optic-nerve pathway concern
Further ophthalmic and visual testing is usually appropriate.
Moderate
Normal amino-acid evaluation
A retinal finding should not be reclassified as a glycine abnormality.
High
How key tests differ
| Test | Abnormal Circulating Glycine Concentration C5139043 | Abnormal Amplitude Of Pattern Electroretinogram C4072975 | Interpretation |
|---|---|---|---|
| Plasma or serum amino acids | Glycine outside the laboratory reference context. | No expected glycine abnormality from this eye finding alone. | Confirm units, reference range, and clinical context; do not infer a diagnosis. |
| Pattern electroretinogram | Not intrinsically abnormal. | Abnormal response amplitude. | Suggests macular or ganglion-cell dysfunction and warrants ophthalmic correlation. |
| Visual acuity and ophthalmic examination | No characteristic eye result is established. | May show visual dysfunction, but findings vary. | Eye testing helps interpret the ERG; it does not assess glycine. |
Prognosis comparison
Abnormal Circulating Glycine Concentration C5139043
- Outcome
- Outcome is not established from abnormal glycine alone.
- Factors
- Direction and degree of abnormality, cause, age, and associated illness matter.
Abnormal Amplitude Of Pattern Electroretinogram C4072975
- Outcome
- Visual outcome is not established from abnormal amplitude alone.
- Factors
- Underlying retinal or ganglion-cell condition and associated examination findings matter.
Time frame: No reliable time course is established for either isolated finding.
Clinician interpretation should integrate history, examination, and confirmatory tests.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic effects | Possible only with certain underlying glycine disorders; not established here. Not a primary feature of the ERG finding. Cause-specific evaluation is required. |
| Vision loss | Not an expected direct consequence. Possible if macular or ganglion-cell dysfunction is significant. Severity cannot be predicted from the label alone. |
| Diagnostic delay | May occur if a blood abnormality is treated as a diagnosis. May occur if further retinal testing is omitted. Both findings need contextual follow-up. |
Patient education highlights
- HighFinding versus diagnosis
An abnormal result identifies a clue, not a confirmed disease or prognosis.
- HighDifferent specialists
Glycine abnormalities are metabolic questions; pattern ERG abnormalities are eye questions.
- MediumFollow-up
Ask which repeat test, specialist review, and warning symptoms apply to your result.